Medicine importers must prove VAT paid on exempt importations was not claimed as input tax credit, or their refund claim may be denied.

Importers claiming a refund or tax credit for VAT paid on VAT-exempt medicines must be ready to prove, through traceable VAT returns, ledgers, and reconciliations, that the same VAT was not already reported and claimed as input tax credit. A refund claim may fail even if the medicine importation is VAT-exempt, when the taxpayer cannot show that the amount claimed was removed from allowable input taxes and was not used against output VAT.

Background of the Refund Dispute

The taxpayer sought a refund or issuance of a tax credit certificate for allegedly erroneously paid value-added tax on importations of VAT-exempt medicines. The amount claimed was ₱26,960,507.62. The claim was anchored on Sections 204(C) and 229 of the National Internal Revenue Code, in relation to Section 109(AA), which covers VAT exemption for certain medicines.

The Court had earlier denied the refund claim in its October 21, 2025 Decision because the taxpayer failed to prove that the VAT claimed for refund had not been reported and claimed as input tax credit in its monthly or quarterly VAT returns, as required under Section 3 of Revenue Regulations No. 18-20. The taxpayer moved for reconsideration, arguing that this proof requirement should not apply to a claim for erroneously paid VAT under Sections 204(C) and 229, because the requirement is more commonly associated with refund claims for unutilized input VAT attributable to zero-rated sales under Section 112 of the Tax Code (CTA Case No. 10773).

The Court Denied the Motion for Reconsideration

The Court denied the taxpayer’s motion for reconsideration for lack of merit. It held that there was no error in requiring the taxpayer to prove that the VAT claimed for refund was not reported and claimed as input tax credit in its VAT returns. The Court clarified that this requirement was not being imposed under Section 112 of the Tax Code. Instead, it arose from Section 3 of Revenue Regulations No. 18-20, which specifically governs refund claims for erroneously paid VAT on importations of VAT-exempt medicines under Section 109(AA).

This distinction is important. The taxpayer tried to frame the issue as though the Court had imported a Section 112 requirement into a Sections 204(C) and 229 refund claim. The Court rejected that framing. It found that Revenue Regulations No. 18-20 itself required proof that the input tax on the imported items had not been reported as input tax credit in monthly or quarterly VAT returns.

Why the VAT Returns and Ledgers Mattered

The taxpayer argued that the imported VAT was reported as input tax allocable to exempt sales. According to the taxpayer, because input tax allocable to exempt sales is deducted from creditable input VAT, the amount could not have been used to reduce output VAT. In practical terms, the taxpayer’s position was that the VAT was already removed from the pool of creditable input taxes and therefore should still be refundable.

The Court, however, found that it could not verify this assertion from the records. It could not trace the amount claimed for refund from the taxpayer’s VAT returns and ledgers in relation to the independent certified public accountant’s findings. The Court noted that even if the input tax allocable to exempt sales per VAT returns was higher than the amount verified by the independent CPA, it could not simply assume that the ₱26,960,507.62 claimed for refund was already included in the amount deducted or removed from allowable input tax credits.

The Court emphasized that the discrepancies were significant. Because of these discrepancies, the taxpayer should have accounted for or reconciled the amounts to eliminate doubt that the refund amount was not also claimed as input tax credit. Without a clear reconciliation, the Court could not grant the claim.

Independent CPA Findings Are Helpful but Not Conclusive

The ruling is also a reminder that findings of an independent CPA in tax refund cases do not automatically bind the Court. Under the Revised Rules of the Court of Tax Appeals, the findings and conclusions of the independent CPA may be adopted by the Court, in whole or in part, but only subject to verification. They may also be challenged by the parties.

For taxpayers, this means that the independent CPA report should not be treated as a substitute for the taxpayer’s own documentary burden. The report may summarize, compute, or validate the claim, but the underlying VAT returns, ledgers, importation documents, accounting schedules, and reconciliations must still allow the Court to trace the claimed amount with reasonable certainty.

The Taxpayer Carries the Burden in Refund and Tax Credit Claims

The Court reiterated the familiar rule that the taxpayer-claimant bears the burden of proving both the legal and factual bases of a claim for tax refund or tax credit. A refund claim is not granted by presumption. The claimant must present sufficient and competent evidence showing that all legal conditions have been satisfied.

Here, the taxpayer attempted to shift the burden to the Commissioner by arguing that if the VAT had been utilized, it was for the Commissioner to prove. The Court rejected this argument. Because proof of non-reporting and non-claiming as input tax credit was a requirement under Revenue Regulations No. 18-20, the taxpayer had the burden to establish that fact. The taxpayer failed to do so.

Practical Takeaways for Pharmaceutical Importers and VAT Refund Claimants

Pharmaceutical companies, healthcare importers, and other taxpayers handling VAT-exempt importations should treat this ruling as a documentation warning. It is not enough to show that the imported goods are VAT-exempt or that VAT was paid at importation. The taxpayer must also prove that the same VAT was not used as input tax credit in VAT returns.

For VAT refund claims involving exempt medicines, taxpayers should prepare a clean reconciliation tying together the import entries, payment documents, VAT schedules, VAT returns, general ledger accounts, input tax ledgers, and the independent CPA’s verified schedules. If the claimed VAT was reported under input tax allocable to exempt sales or under purchases not qualified for input tax, the taxpayer should be able to trace that treatment directly and explain any difference between return amounts, ledger balances, and CPA-verified figures.

The ruling is also relevant beyond pharmaceutical importations. It reinforces the broader litigation principle that tax refund claims are evidence-heavy proceedings. Courts will not assume entitlement from accounting labels alone. Where figures do not reconcile, the taxpayer must explain the variances before the Court can conclude that the government is holding tax that should legally be returned.

How Ablola, Saribong & Gueco Can Assist

Ablola, Saribong & Gueco assists taxpayers, importers, and corporate finance teams in preparing, documenting, and litigating tax refund and tax credit claims before the Bureau of Internal Revenue and the Court of Tax Appeals. Our tax litigation practice can help evaluate whether a VAT refund claim is properly supported, identify evidentiary gaps, prepare reconciliation schedules, coordinate with independent CPAs, and build the factual record needed for trial.

For businesses dealing with denied VAT refund claims, disputed input tax treatment, or Court of Tax Appeals litigation, visit MakatiLawFirm.com to consult our tax litigation team.


Leave a Comment

Your email address will not be published. Required fields are marked *